Advances in sepsis biomarkers

Adv Clin Chem. 2024:119:117-166. doi: 10.1016/bs.acc.2024.02.003. Epub 2024 Feb 15.

Abstract

Sepsis, a dysregulated host immune response to an infectious agent, significantly increases morbidity and mortality for hospitalized patients worldwide. This chapter reviews (1) the basic principles of infectious diseases, pathophysiology and current definition of sepsis, (2) established sepsis biomarkers such lactate, procalcitonin and C-reactive protein, (3) novel, newly regulatory-cleared/approved biomarkers, such as assays that evaluate white blood cell properties and immune response molecules, and (4) emerging biomarkers and biomarker panels to highlight future directions and opportunities in the diagnosis and management of sepsis.

Keywords: Clinical laboratory test; Diagnosis; Immune response; Infection; Prognosis.

MeSH terms

  • Biomarkers
  • C-Reactive Protein
  • Humans
  • Lactic Acid
  • Sepsis* / diagnosis

Substances

  • Biomarkers
  • C-Reactive Protein
  • Lactic Acid